iptacopan
Commercial- Indications
- Paroxysmal nocturnal hemoglobinuria, Immunoglobulin A nephropathy
Company intelligence / Profile preview
Dojin Iyaku-Kako Co., Ltd. specializes in the contract manufacturing of pharmaceuticals including oral solutions, capsules with advanced coatings, topical drugs such as patches/plasters, and small molecule generics. The company has at least one approved drug product—Diclofenac Sodium for tendinopathy—and supports clients across multiple therapeutic areas through its CMO services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dojin Iyaku-Kako Co., Ltd..